Showing results (131-140 of 434) with videos related to
Sort By:
Pageof 44
Plos One|June 23, 2011
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinomaMichael P Kim, Jason B Fleming, Huamin Wang, et al.European Radiology|March 21, 2020
Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should knowMarco Calandri, Giulia Siravegna, Steven M Yevich, et al.Clinical Colorectal Cancer|October 2, 2020
Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon CancerSongphol Malakorn, Akira Ouchi, Chung-Yuan Hu, et al.Cancer|May 16, 2015
Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancerManasi S Shah, David R Fogelman, Kanwal Pratap Singh Raghav, et al.Future Oncology (London, England)|October 10, 2023
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRCElena Elez, Scott Kopetz, Josep Tabernero, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation StatusYoshikuni Kawaguchi, Scott Kopetz, Heather A Lillemoe, et al.JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.Clinical Colorectal Cancer|September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 casesMichael J Overman, David Fogelman, Aref Al-Kali, et al.The Oncologist|March 13, 2020
Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon CancerIrene S Yu, Allan A L Pereira, Michael Lee, et al.European Journal of Cancer (Oxford, England : 1990)|December 29, 2023
Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markersAmos Stemmer, Ofer Margalit, Victoria Serpas, et al.Pageof 44